Strong Dollar Remains Headache For Johnson & Johnson

April 15, 2015   |   April 2015 Bond Updates
The continued climb of the U.S. dollar weighed heavily on pharmaceutical giant Johnson & Johnson's first quarter earnings reported Tuesday morning.

View more at: http://www.forbes.com/sites/samanthasharf/2015/04/14/strong-dollar-remains-headache-for-johnson-johnson/
 
Related News
Home| About us | Contact us http://www.bondupdatesdailynews.com/